Alfred J. Ford Jr. - 17 Jul 2025 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Role
Chief Commercial Officer
Signature
/s/ Alfred J. Ford, Jr.
Issuer symbol
KMTS
Transactions as of
17 Jul 2025
Net transactions value
$0
Form type
4
Filing time
21 Jul 2025, 17:09:35 UTC
Previous filing
15 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ford Alfred J Jr Chief Commercial Officer C/O KESTRA MEDICAL TECHNOLOGIES, LTD., 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND /s/ Alfred J. Ford, Jr. 21 Jul 2025 0001359446

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KMTS Common Shares Award $0 +29,412 $0.000000 29,412 17 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KMTS Options 118,000 17 Jul 2025 Common Shares 118,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSU's will vest 9,804 on July 17, 2026, 9,804 on July 17, 2027 and 9,804 on July 17, 2028.
F2 Includes 59,000 options that will vest on March 6, 2026, and the remaining 59,000 will vest monthly over the following year.

Remarks:

Exhibit 24.1 - Power of Attorney